Question 1

What is PONESIMOD used for?

Accepted Answer

PONESIMOD (brand name PONVORY) is a S1P Receptor Modulator indicated for 1 INDICATIONS AND USAGE PONVORY is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease.

Question 2

How does PONESIMOD work?

Accepted Answer

PONESIMOD works through the following mechanism: 12.1 Mechanism of Action Ponesimod is a S1P receptor 1 modulator that binds with high affinity to S1P receptor 1. Ponesimod blocks the capacity of lymphocytes to egress from lymph nodes, reducing the number of lymphocytes in peripheral blood. The mechanism by which ponesimod exerts therapeutic effects in MS is unknown, but may involve reduction of lymphocyte migration into the central nervous system..

Question 3

What are the most common side effects of PONESIMOD?

Accepted Answer

Reported side effects vary by individual. The side-effects section on this page lists the events most frequently reported to FDA FAERS for PONESIMOD. FAERS is voluntary reporting, so it reflects what was reported, not absolute incidence.

Question 4

Is PONESIMOD the same as PONVORY?

Accepted Answer

PONVORY is a brand name for PONESIMOD. They share the same active ingredient and FDA-approved indications. Biosimilars and authorised generics may differ in inactive ingredients such as buffers or preservatives.

PONESIMOD

Mechanism of Action

Indications

FDA Warnings

Known Side Effects

Community Discussions

Primary sources

Compare With

Formulations